Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8-10/CD44v10 competitive RT-PCR

International Journal of Cancer

Volumn 79, Issue 6, 1998, Pages 560-564

  Miyake, Hideaki ^a,b   Okamoto, Isamu ^a   Hiara, Isao ^b   Gohji, Kazuo ^b   Yamanaka, Kazuki ^b   Arakawa, Soichi ^b   Kamidono, Sadao ^b   Saya, Hideyuki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINALYSIS; UROGENITAL TRACT CANCER;

ADOLESCENT; ADULT; AGED; ALTERNATIVE SPLICING; ANTIGENS, CD44; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UROLOGIC DISEASES; UROLOGIC NEOPLASMS;

EID: 0031738791     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981218)79:6<560::AID-IJC2>3.0.CO;2-X     Document Type: Article

References (21)

1. ARCH, R., WIRTH, K., HOFMANN, M., PONTA, H., MATZKU, S., HERRLICH, P. and ZOLLER, M., Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science, 257, 682-685 (1992).
2. BARTOLAZZI, A., PEACH, R., ARUFFO, A. and STAMENKOVIC, I., Interaction between CD44 and hyarulonate is directory implicated in the regulation of tumor development. J. exp. Med., 180, 53-66 (1994).
3. GOTLEY, D.C., FAWCETT, J., WALSH, M.D., REEDER, J.A., SIMMONS, D.L. and ANTALIS, T.M., Alternatively spliced variants or the cell adhesion molecule CD44 and tumor progression in colorectal cancer. Brit. J. Cancer, 74, 5292-5297 (1996).
4. GÜNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZÖLLER, M., HAUBMANN, I., MATZKU, S., WENZEL, A., PONTA, H. and HERRLICH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma. Cell, 65, 13-24 (1991).
5. HENEY, N.M., Natural history of bladder cancer. Urol. Clin. North Amer., 19, 429-435 (1992).
6. KAUFMANN M., HEIDER, K.H., SINN, H.P., VON, M.G., PONTA, H. and HERRLICH, P., CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345, 615-619 (1995).
7. KINOSHITA, H., OGAWA, O.. KAKEHI, Y., MISHINA, M., MITSUMORI, K., ITOH, N., YAMADA, H., TERACHI, T. and YOSHIDA, O., Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J. nat. Cancer Inst., 89, 724-730 (1997).
8. KOSS, L.G., DEITCH, D., RAMAMATHAN, R. and SHERMAN, A.B., Diagnostic value of cytology of voided urine. Acta cytol., 29, 810-816 (1985).
9. MAO, L., SCHOENBERG, M.P., SCICCHITANO, M., EROZAN, Y.S., MERLO, A., SCHWAB, D. and SIDRANSKY, D., Molecular detection of primary bladder cancer by microsatellite analysis. Science, 271, 659-662 (1996).
10. MATSUMURA, Y., HANBURY, D., SMITH, J. and TARIN, D., Non-invasive detection of malignancy by identification of usual CD44 gene activity in exfoliated cancer cells. Brit. Med. J., 308, 619-624 (1994).
11. MIWA, T., WATANABE, A., YAMADA, Y., SHINO, Y., YAMADA, T., YAMASHITA, J., MATSUDA, M. and NAKANO, H., Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript. Cancer, 77, 25-29 (1996).
12. MIYAKE, H., HARA, T., FUJISAWA, M., ETO, H., OKADA, H., ARAKAWA, S. and KAMIDONO, S., Prognostic significance in patients with upper urinary tract cancer. Int. J. Clin. Oncol., 1, 135-138 (1996).
13. MIYAKE, H., HARA, I., YAMANAKA, K., GOHJI, K., ARAKAWA, S. and KAMIDONO, S., Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes. Amer. J. Pathol., 152, 1157-1160 (1998).
14. OKAMOTO, I., MORISAKI, T., SASAKI, J., MIYAKE, H., MATSUMOTO, M., SUGA, M., ANDO, M. and SAYA, H.. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs. J. nat. Cancer Inst., 90, 307-315 (1998).
15. RODRIGUEZ, C., MONGES, G., ROUANET, P., DUTRILLAUX, B., LEFRANÇOIS, D. and THEILLET, C., CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants. Int. J. Cancer, 64, 347-354 (1995).
16. SAROSDY, M.F., WHITE, R.W., SOLOWAY, M.S., SHEINFELD, J., HUDSON, M.A., SCHELLHAMMER, P.F., JAROWENKO, M.V., ADAMS, G. and BLUMENSTEIN, B.A., Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J. Urol., 154, 379-384 (1995).
17. SASAKI, J., TANABE, K.K., TAKAHASHI, K., OKAMOTO, I., FUJIMOTO, H., MATSUMOTO, M., SUGA, M., ANDO, M. and SAYA, H., Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas. Int. J. Oncol., 12, 525-533 (1998).
18. SOUTHGATE, J., TREJDOSIEWICZ, L.K., SMITH, B. and SELBY, J., Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines. Int. J. Cancer, 62, 449-456 (1995).
19. TAKAO, T., SUMIZAKI, H., NAKANO, K., MATSUZUKA, F., KUMA, K. and AMINO, N. Increased expression of CD44 variants in differentiated thyroid cancers. Jpn. J. Cancer Res., 87, 1245-1250 (1996).
20. TANABE, K.K., ELLIS, L.M. and SAYA, H., Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet, 341, 725-726 (1993a).
21. TANABE, K.K., NISHI, T. and SAYA, H., Novel variants of CD44 arising from alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase. Mol. Carcinogenesis, 7, 212-220 (1993b).